Theravance Biopharma, Inc. (TBPH)
17.00
-0.01
(-0.06%)
USD |
NASDAQ |
Aug 24, 16:00
17.00
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Total Assets (Quarterly) : 469.77M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 469.77M |
| March 31, 2026 | 472.31M |
| December 31, 2025 | 485.57M |
| September 30, 2025 | 415.46M |
| June 30, 2025 | 426.04M |
| March 31, 2025 | 343.58M |
| December 31, 2024 | 354.16M |
| September 30, 2024 | 356.10M |
| June 30, 2024 | 362.03M |
| March 31, 2024 | 371.31M |
| December 31, 2023 | 382.00M |
| September 30, 2023 | 413.59M |
| June 30, 2023 | 446.63M |
| March 31, 2023 | 538.55M |
| December 31, 2022 | 607.40M |
| September 30, 2022 | 763.50M |
| June 30, 2022 | 360.76M |
| March 31, 2022 | 355.36M |
| December 31, 2021 | 374.82M |
| September 30, 2021 | 403.11M |
| June 30, 2021 | 429.25M |
| March 31, 2021 | 375.11M |
| December 31, 2020 | 469.06M |
| September 30, 2020 | 512.19M |
| June 30, 2020 | 564.33M |
| Date | Value |
|---|---|
| March 31, 2020 | 605.41M |
| December 31, 2019 | 408.83M |
| September 30, 2019 | 445.34M |
| June 30, 2019 | 492.45M |
| March 31, 2019 | 531.26M |
| December 31, 2018 | 560.24M |
| September 30, 2018 | 370.96M |
| June 30, 2018 | 421.36M |
| March 31, 2018 | 480.11M |
| December 31, 2017 | 441.40M |
| September 30, 2017 | 486.16M |
| June 30, 2017 | 543.89M |
| March 31, 2017 | 588.04M |
| December 31, 2016 | 639.25M |
| September 30, 2016 | 356.29M |
| June 30, 2016 | 374.49M |
| March 31, 2016 | 293.12M |
| December 31, 2015 | 300.12M |
| September 30, 2015 | 257.51M |
| June 30, 2015 | 289.48M |
| March 31, 2015 | 324.90M |
| December 31, 2014 | 337.77M |
| September 30, 2014 | 381.70M |
| June 30, 2014 | 430.59M |
| March 31, 2014 | 26.17M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Zymeworks, Inc. | 396.96M |
| Viatris, Inc. | 35.04B |
| Ocular Therapeutix, Inc. | 671.32M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 180.06M |
| Shareholders Equity (Quarterly) | 289.70M |
| Debt to Equity Ratio | 0.2463 |
| Current Ratio | 13.54 |
| Net Debt Paydown Yield | 0.18% |